Skip to content
1887
Volume 61, Issue 1
  • ISSN: 2056-5135

Abstract

It was some 50 years ago that Barnett Rosenberg and coworkers published their studies on unusual patterns of bacterial growth that led to the identification of platinum compounds as highly effective agents against some cancers, particularly those of genitourinary origin. This sparked a renewed interest around the world in the potential of metal compounds as small molecule therapeutic agents. Some of that history, particularly related to the platinum group metals (pgm) platinum and ruthenium, is described in this overview.

Loading

Article metrics loading...

/content/journals/10.1595/205651317X693624
2017-01-01
2024-07-22
Loading full text...

Full text loading...

/deliver/fulltext/jmtr/61/1/JMTR-61-1-Barnard.html?itemId=/content/journals/10.1595/205651317X693624&mimeType=html&fmt=ahah

References

  1. Reedijk J. Platinum Metals Rev., 2008, 52, (1), 2 LINK http://www.technology.matthey.com/article/52/1/2-11/ [Google Scholar]
  2. Rosenberg B., Van Camp L., and Krigas T. Nature, 1965, 205, (4972), 698 LINK http://dx.doi.org/10.1038/205698a0 [Google Scholar]
  3. Rosenberg B., VanCamp L., Trosko J. E., and Mansour V. H. Nature, 1969, 222, (5191), 385 LINK http://dx.doi.org/10.1038/222385a0 [Google Scholar]
  4. Jamieson E. R., and Lippard S. J. Chem. Rev., 1999, 99, (9), 2467 LINK http://dx.doi.org/10.1021/cr980421n [Google Scholar]
  5. Ohndorf U.-M., Rould M. A., He Q., Pabo C. O., and Lippard S. J. Nature, 1999, 399, (6737), 708 LINK http://dx.doi.org/10.1038/21460 [Google Scholar]
  6. Cvitkovic E., Spaulding J., Bethune V., Martin J., and Whitmore W. F. Cancer, 1977, 39, (4), 1357 LINK http://dx.doi.org/10.1002/1097-0142(197704)39:4<1357::AID-CNCR2820390402>3.0.CO;2-C [Google Scholar]
  7. Cleare M. J., and Hoeschele J. D. Bioinorg. Chem., 1973, 2, (3), 187 LINK http://dx.doi.org/10.1016/S0006-3061(00)80249-5 [Google Scholar]
  8. Cleare M. J. Coord. Chem. Rev., 1974, 12, (4), 349 LINK http://dx.doi.org/10.1016/S0010-8545(00)82029-9 [Google Scholar]
  9. Connors T. A., Cleare M. J., and Harrap K. R. Cancer Treat. Rep., 1979, 63, (9–10), 1499 LINK https://www.ncbi.nlm.nih.gov/pubmed/498149 [Google Scholar]
  10. Harrap K. R. Cancer Treat. Rev., 1985, 12, (A), 21 LINK http://dx.doi.org/10.1016/0305-7372(85)90015-5 [Google Scholar]
  11. Barnard C. F. J., Cleare M. J., and Hydes P. C. Chem. Br., 1986, 22, 1001 [Google Scholar]
  12. Wheate N. J., Walker S., Craig G. E., and Oun R. Dalton Trans., 2010, 39, (35), 8113 LINK http://dx.doi.org/10.1039/c0dt00292e [Google Scholar]
  13. Vermorken J. B., ten Bokkel Huinink W. W., McVie J. G., van der Vijgh W. J. F., Pinedo H. M., and Krakoff I. H. ‘Clinical Experience with 1,1-Diaminomethylcyclohexane (Sulphato) Platinum (II) (TNO-6)’, Platinum Coordination Complexes in Cancer Chemotherapy, Vermont Regional Cancer Center and the Norris Cotton Cancer Center, USA, 22nd–24th June, 1983, “Proceedings of the Fourth International Symposium on Platinum Coordination Complexes in Cancer Chemotherapy”, eds. Hacker M. P., Douple E. B., Martinus Nijhoff Publishing, Boston, USA, 1984, p. 330 [Google Scholar]
  14. Christian M. C. Semin. Oncol., 1992, 19, (6), 720 [Google Scholar]
  15. Mathé G., Kidani Y., Noji M., Maral R., Bourut C., and Chenu E. Cancer Lett., 1985, 27, (2) 135 LINK http://dx.doi.org/10.1016/0304-3835(85)90102-8 [Google Scholar]
  16. Mathé G., Kidani Y., Triana K., Brienza S., Ribaud P., Goldschmidt E., Ecstein E., Despax R., Musset M., and Misset J. L. Biomed. Pharmacother., 1986, 40, (10), 372 LINK https://www.ncbi.nlm.nih.gov/pubmed/3580505 [Google Scholar]
  17. Boughattas A. N., Lévi F., Fournier C., Lemaigre G., Roulon A., Hecquet B., Mathé G., and Reinberg A. Cancer Res., 1989, 49, (12), 3362 LINK https://www.ncbi.nlm.nih.gov/pubmed/2720689 [Google Scholar]
  18. Lévi F., Misset J.-L., Brienza S., Adam R., Metzger G., Itzakhi M., Caussanel J. P., Kunstlinger F., Lecouturier S., Descorps-Declère A., Jasmin C., Bismuth H., and Reinberg A. Cancer, 1992, 69, (4), 893 LINK https://doi.org/10.1002/1097-0142(19920215)69:4%3C893::AID-CNCR2820690410%3E3.0.CO;2-X [Google Scholar]
  19. Giandomenico C. M., Abrams M. J., Murrer B. A., Vollano J. F., Rheinheimer M. I., Wyer S. B., Bossard G. E., and Higgins J. D. Inorg. Chem., 1995, 34, (5), 1015 LINK http://dx.doi.org/10.1021/ic00109a004 [Google Scholar]
  20. McKeage M. J., Mistry P., Ward J., Boxall F. E., Loh S., O’Neill C., Ellis P., Kelland L. R., Morgan S. E., Murrer B. A., Santabarbara P., Harrap K. R., and Judson I. R. Cancer Chemother. Pharmacol., 1995, 36, (6), 451 LINK http://dx.doi.org/10.1007/BF00685793 [Google Scholar]
  21. Thayer A. M. Chem. Eng. News, 2010, 88, (26), 24 LINK http://dx.doi.org/10.1021/cen-v088n026.p024 [Google Scholar]
  22. Kelland L. R., and Barnard C. F. J. Drugs Fut., 1998, 23, (10), 1062 LINK http://dx.doi.org/10.1358/dof.1998.023.10.473361 [Google Scholar]
  23. Kelland L. R., Sharp S. Y., O’Neill C. F., Raynaud F. I., Beale P. J., and Judson I. R. J. Inorg. Biochem., 1999, 77, (1–2), 111 LINK http://dx.doi.org/10.1016/S0162-0134(99)00141-5 [Google Scholar]
  24. Kelland L. R., Barnard C. F. J., Evans I. G., Murrer B. A., Theobald B. R. C., Wyer S. B., Goddard P. M., Jones M., Valenti M., Bryant A., Rogers P. M., and Harrap K. R. J. Med. Chem., 1995, 38, (16), 3016 LINK http://dx.doi.org/10.1021/jm00016a004 [Google Scholar]
  25. Kelland L. R., Barnard C. F. J., Mellish K. J., Jones M., Goddard P. M., Valenti M., Bryant A., Murrer B. A., and Harrap K. R. Cancer Res., 1994, 54, (21), 5618 LINK https://www.ncbi.nlm.nih.gov/pubmed/7923207 [Google Scholar]
  26. Mellish K. J., Barnard C. F. J., Murrer B. A., and Kelland L. R. Int. J. Cancer, 1995, 62, (6), 717 LINK http://dx.doi.org/10.1002/ijc.2910620612 [Google Scholar]
  27. Goddard P. M., Orr R. M., Valenti M. R., Barnard C. F. J., Murrer B. A., Kelland L. R., and Harrap K. R. Anticancer Res., 1996, 16, (1), 33 LINK https://www.ncbi.nlm.nih.gov/pubmed/8615631 [Google Scholar]
  28. Farrell N., Kelland L. R., Roberts J. D., and Van Beusichem M. Cancer Res., 1992, 52, (18), 5065 LINK https://www.ncbi.nlm.nih.gov/pubmed/1516063 [Google Scholar]
  29. Farrell N. Cancer Invest., 1993, 11, 578 [Google Scholar]
  30. Lovejoy K. S., and Lippard S. J. Dalton Trans., 2009, (48), 10651 LINK http://dx.doi.org/10.1039/b913896j [Google Scholar]
  31. Jodrell D. I., Evans T. R. J., Steward W., Cameron D., Prendiville J., Aschele C., Noberasco C., Lind M., Carmichael J., Dobbs N., Camboni G., Gatti B., and De Braud F. Eur. J. Cancer, 2004, 40, (12), 1872 LINK http://dx.doi.org/10.1016/j.ejca.2004.04.032 [Google Scholar]
  32. Hensing T. A., Hanna N. H., Gillenwater H. H., Camboni M. G., Allievi C., and Socinski M. A. Anticancer Drugs, 2006, 17, (6), 697 LINK http://dx.doi.org/10.1097/01.cad.0000215054.62942.7f [Google Scholar]
  33. Clarke M. J. Met. Ions Biol. Syst., 1980, 11, 231 [Google Scholar]
  34. Sava G., Alessio E., Bergamo A., Mestroni G., and Sadler P. J. ‘Sulfoxide Ruthenium Complexes: Non Toxic Tools for the Selective Treatment of Solid Tumour Metastases’, in “Metallopharmaceuticals I”, eds. Clarke M. J., Topics in Biological Inorganic Chemistry, Springer-Verlag, Heidelberg, Germany, 1999, p. 143 [Google Scholar]
  35. Leijen S., Burgers S. A., Baas P., Pluim D., Tibben M., van Werkhoven E., Alessio E., Sava G., Beijnen J. H., and Schellens J. H. M. Invest. New Drugs, 2015, 33, (1), 201 LINK http://dx.doi.org/10.1007/s10637-014-0179-1 [Google Scholar]
  36. Trondl R., Heffeter P., Kowol C. R., Jakupec M. A., Berger W., and Keppler B. K. Chem. Sci., 2014, 5, (8), 2925 LINK http://dx.doi.org/10.1039/C3SC53243G [Google Scholar]
  37. Bergamo A., and Sava G. Dalton Trans., 2011, 40, (31), 7817 LINK http://dx.doi.org/10.1039/c0dt01816c [Google Scholar]
  38. Yan Y. K., Melchart M., Habtemariam A., and Sadler P. J. Chem. Commun., 2005, (38), 4764 LINK http://dx.doi.org/10.1039/b508531b [Google Scholar]
  39. Noffke A. L., Habtemariam A., Pizarro A. M., and Sadler P. J. Chem. Commun., 2012, 48, (43), 5219 LINK http://dx.doi.org/10.1039/c2cc30678f [Google Scholar]
  40. Ang W. H., Daldini E., Scolaro C., Scopelliti R., Juillerat-Jeannerat L., and Dyson P. J. Inorg. Chem., 2006, 45, (22), 9006 LINK http://dx.doi.org/10.1021/ic061008y [Google Scholar]
  41. Serli B., Zangrando E., Gianferrara T., Scolaro C., Dyson P. J., Bergamo A., and Alessio E. Eur. J. Inorg. Chem., 2005, (17), 3423 LINK http://dx.doi.org/10.1002/ejic.200500210 [Google Scholar]
  42. Bratsos I., Jedner S., Bergamo A., Sava G., Gianferrara T., Zangrando E., and Alessio E. J. Inorg. Biochem., 2008, 102, (5–6), 1120 LINK http://dx.doi.org/10.1016/j.jinorgbio.2008.01.005 [Google Scholar]
  43. Süss-Fink G. Dalton Trans., 2010, 39, (7), 1673 LINK http://dx.doi.org/10.1039/B916860P [Google Scholar]
  44. Clavel C. M., Paunescu E., Nowak-Sliwinska P., Griffioen A. W., Scopelliti R., and Dyson P. J. J. Med. Chem., 2014, 57, 3546 LINK http://dx.doi.org/10.1021/jm5002748 [Google Scholar]
  45. Meng X., Leyva M. L., Jenny M., Gross I., Benosman S., Fricker B., Harlepp S., Hébraud P., Boos A., Wlosik P., Bischoff P., Sirlin C., Pfeffer M., Loeffler J.-P., and Gaiddon C. Cancer Res., 2009, 69, (13), 5458 LINK http://dx.doi.org/10.1158/0008-5472.CAN-08-4408 [Google Scholar]
/content/journals/10.1595/205651317X693624
Loading
/content/journals/10.1595/205651317X693624
Loading

Data & Media loading...

  • Article Type: Research Article
This is a required field
Please enter a valid email address
Approval was a Success
Invalid data
An Error Occurred
Approval was partially successful, following selected items could not be processed due to error